acquisition

Klotho Neurosciences rebrands to Greenland Mines Ltd, shifting from neuroscience to natural resources with focus on a $68 billion palladium deposit in Greenland.

Agilent acquires Biocare Medical for $950M to expand pathology and immunohistochemistry capabilities. Deal expected accretive to EPS within 12 months, closing by Q4 2026.

Woodward acquires Florida-based VRM to strengthen aerospace flow control capabilities, adding solenoid and relief valves to its portfolio. Deal closes H1 2026.

Microsoft offers better value than Netflix despite recent losses, as it capitalizes on AI infrastructure demand with proven monetization paths versus Netflix's streaming competition.

Netflix rebounds to $100/share after failed Warner Bros. Discovery deal, posting 16% revenue growth. Analysts see $150 potential amid streaming competition.

Cannabis leader $CGC has crashed 99% from $568 peak to ~$1, facing profitability challenges and dilutive acquisition amid intense competition.

Lisata Therapeutics agreed to be acquired by Kuva Labs for $5.00 per share plus up to $1.00 contingent payment, closing expected in Q2 2026.

Lisata Therapeutics agrees to be acquired by Kuva Labs for $5 per share plus up to $1 contingent payment tied to FDA approval, with close expected in Q2 2026.

Tevogen Bio ($TVGN) pursues Apozeal acquisition to bolster generics platform; stock plunges 15.41% despite initial rally, trading at 52-week lows amid strategic uncertainty.

Prediction market traders assign 68% probability to Caesars Entertainment acquisition in 2026, with potential bidders including Tilman Fertitta. Analysts caution investors to focus on fundamentals over M&A speculation.

Diana Shipping escalates takeover battle, raising Genco offer to $23.50/share from $20.60 amid Star Bulk vessel acquisition.

Luckin's controlling shareholder Centurium Capital acquired Blue Bottle Coffee from Nestlé for under $400 million, well below the $700 million asking price, while maintaining separate brand operations.

Diana Shipping increases all-cash offer for Genco Shipping to $23.50/share, a 31% premium, with $1.433B in committed financing and Star Bulk's vessel purchase agreement.

Servier acquires Day One Biopharmaceuticals for $2.5B in cash, expanding rare pediatric oncology portfolio with closing expected Q2 2026.

VEON subsidiary acquires controlling stake in TPL Insurance for $14.6M to integrate insurance with JazzCash and Mobilink Bank platforms in Pakistan.

Quipt Home Medical receives final court approval for US$3.65/share acquisition by Kingswood and Forager Capital affiliates, with delisting expected by March 2026.

Quipt Home Medical gains final court approval for US$3.65/share acquisition by Kingswood and Forager Capital affiliates, with delisting expected by March 2026.

Baker Hughes prices $9.5B debt offering to fund Chart Industries acquisition, with notes maturing through 2056 and closing expected March 11, 2026.

Bel Fuse acquires dataMate for $16M, gaining $18M in annual sales and US manufacturing capabilities with immediately accretive earnings impact.

Tevogen Bio signs Letter of Intent to acquire Apozeal Pharmaceutical, gaining 11 FDA-approved generics and pipeline assets to expand domestic manufacturing strategy.